Corporate Corruption News Articles

Excerpts of key news articles on

Below are key excerpts of revealing news articles on corporate corruption from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

Note: Explore our full index to revealing excerpts of key major media news articles on dozens of engaging topics. And read excerpts from 20 of the most revealing news articles ever published.

Newly released documents show an influential group that helps shape US food policy and steers consumers toward nutritional products has financial ties to the world's largest processed food companies and has been controlled by former industry employees who have worked for companies like Monsanto. The documents reveal the Academy of Nutrition and Dietetics has a record of quid pro quos with a range of food giants, owns stock in ultra-processed food companies and has received millions in contributions from producers of pop, candy, and processed foods linked to diabetes, heart disease, obesity and other health problems. The findings are a part of a recently published peer-reviewed study that examined a trove of financial documents and internal communications obtained through a Freedom of Information Act (Foia) request. "It's incredibly influential so if the Academy is corrupt then nutritional policy in the US is going to be corrupt," said Gary Ruskin ... a co-author of the study. The Academy accepted at least $15m from corporate and organizational contributors from 2011-2017, and over $4.5m in additional funding went to the Academy's foundation. Among the highest contributions came from companies such as NestlÄ‚©, PepsiCo, Hershey, Kellogg's, General Mills, Conagra, the National Dairy Council and the baby formula producer Abbott Nutrition. The Academy and its foundation also received food industry fundings via sponsorships, which are in effect quid pro quos.

Note: For more along these lines, see concise summaries of deeply revealing news articles on food system corruption from reliable major media sources.

A colonoscopy might cost you or your insurer a few hundred dollars – or several thousand, depending on which hospital or insurer you use. Long hidden, such price variations are supposed to be available in stark black and white under a Trump administration price transparency rule that took effect at the start of this year. It requires hospitals to post a range of actual prices – everything from the rates they offer cash-paying customers to costs negotiated with insurers. While imperfect and potentially of limited use right now to the average consumer, the disclosures that are available illustrate the huge differences in prices – nationally, regionally and within the same hospital. Prices are all over the map. In Virginia, for example, the average price of a diagnostic colonoscopy is $2,763, but the range across the state is from $208 to $10,563. Patients can try to find the price information themselves by searching hospital websites, but even locating the correct tab on a hospital's website is tricky. But if you do want to try, here's one tip: "You can Google the hospital name and the words 'price transparency' and see where that takes you," says Caitlin Sheetz, director and head of analytics at the consulting firm ADVI Health. When it comes to compliance, "we're seeing the range of the spectrum," says Jeffrey Leibach, a partner at the consulting firm Guidehouse, which found earlier this year that about 60% of 1,000 hospitals surveyed had posted at least some data, but 30% had reported nothing at all.

Note: For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.

In "Why the Innocent Plead Guilty and the Guilty Go Free: And Other Paradoxes of Our Broken Legal System," [Judge Jed S.] Rakoff reaches far beyond corporate boardrooms to highlight an array of shortcomings within the criminal justice system. His proposed fixes are worthy of consideration but also lay bare a harsh reality: The entrenched interests tolerating the system's inequities and, in some cases, profiting from the status quo pose significant obstacles to reform. Rakoff realized that America's "system of justice is failing its mission" after becoming a federal district court judge a quarter-century ago. What's the nature of this failure? The country imprisons millions of indigent Americans yet routinely allows white-collar criminals to avoid punishment. "To a federal judge," he declares, the government's reluctance to hold executives accountable and instead enter into "cosmetic prosecution agreements" with corporations that are repeatedly violated and unenforced "is disturbing ... in what it says about the DOJ's apparent disregard for equality under the law." Rakoff fittingly cites Pfizer to exemplify his point. The four deferred-prosecution agreements between the pharmaceutical giant and federal authorities from 2002 to 2009 – all devised to prevent future misconduct – failed to stop the company from flouting the law. Through it all, Pfizer's executives went unpunished, and the fines the company paid represented a fraction of its ill-gotten gains.

Note: For a much deeper analysis and discussion of Judge Rakoff's highly revealing book by courageous journalist Matt Taibbi, see this excellent essay. Consider subscribing to Taibbi's excellent work. For more along these lines, see concise summaries of deeply revealing news articles on corruption in the court system and in Big Pharma from reliable major media sources.

The announcement this week that a cheap, easy-to-make coronavirus vaccine appeared to be up to 90 percent effective was greeted with jubilation. But since unveiling the preliminary results, AstraZeneca has acknowledged a key mistake in the vaccine dosage received by some study participants, adding to questions about whether the vaccine's apparently spectacular efficacy will hold up under additional testing. Scientists and industry experts said the error and a series of other irregularities and omissions in the way AstraZeneca initially disclosed the data have eroded their confidence in the reliability of the results. The regimen that appeared to be 90 percent effective was based on participants receiving a half dose of the vaccine followed a month later by a full dose; the less effective version involved a pair of full doses. AstraZeneca disclosed in its initial announcement that fewer than 2,800 participants received the smaller dosing regimen, compared with nearly 8,900 participants who received two full doses. Moncef Slaoui, the head of Operation Warp Speed, the U.S. initiative to fast-track coronavirus vaccines, noted another limitation in AstraZeneca's data. On a call with reporters, he suggested that the participants who received the half-strength initial dose had been 55 years old or younger. The fact that the initial half-strength dose wasn't tested in older participants, who are especially vulnerable to Covid-19, could undermine AstraZeneca's case to regulators that the vaccine should be authorized for emergency use.

Note: Learn in this revealing article how vaccine trials are rigged. This article spells out how vaccine makers are above the law and face no consequences for damage from vaccines. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and vaccines from reliable major media sources.

On June 26, a small South San Francisco company called Vaxart made a surprise announcement: A coronavirus vaccine it was working on had been selected by the U.S. government to be part of Operation Warp Speed, the flagship federal initiative to quickly develop drugs to combat Covid-19. The race is on to develop a coronavirus vaccine, and some companies and investors are betting that the winners stand to earn vast profits from selling hundreds of millions – or even billions – of doses to a desperate public. Across the pharmaceutical and medical industries, senior executives and board members ... are making millions of dollars after announcing positive developments, including support from the government, in their efforts to fight Covid-19. After such announcements, insiders from at least 11 companies – most of them smaller firms whose fortunes often hinge on the success or failure of a single drug – have sold shares worth well over $1 billion since March. Senior officials appear to be pouncing on opportunities to cash out. And some companies have awarded stock options to executives shortly before market-moving announcements about their vaccine progress. Some companies are attracting government scrutiny for ... using their associations with Operation Warp Speed as marketing ploys. Vaxart's news release declared: "Vaxart's Covid-19 Vaccine Selected for the U.S. Government's Operation Warp Speed." But Vaxart is not among the companies selected to receive significant financial support from Warp Speed.

Note: MSN strangely removed this article a few days after posting it. A similar article by the New York Times titled "The race for a coronavirus vaccine is making some corporate insiders very rich" is available here. For more along these lines, see concise summaries of deeply revealing news articles on big Pharma corruption and the coronavirus from reliable major media sources.

An explosive leak of tens of thousands of documents from the defunct data firm Cambridge Analytica is set to expose the inner workings of the company that collapsed after the Observer revealed it had misappropriated 87 million Facebook profiles. More than 100,000 documents relating to work in 68 countries that will lay bare the global infrastructure of an operation used to manipulate voters on “an industrial scale” are set to be released over the next months. The documents were revealed to have come from Brittany Kaiser, an ex-Cambridge Analytica employee turned whistleblower, and to be the same ones subpoenaed by Robert Mueller’s investigation into Russian interference in the 2016 presidential election. Kaiser ... decided to go public after last month’s election in Britain. “It’s so abundantly clear our electoral systems are wide open to abuse,” she said. “I’m very fearful about what is going to happen in the US election later this year.” Kaiser said the Facebook data scandal was part of a much bigger global operation that worked with governments, intelligence agencies, commercial companies and political campaigns to manipulate and influence people. The unpublished documents contain material that suggests the firm was working for a political party in Ukraine in 2017 even while under investigation as part of Mueller’s inquiry and emails that Kaiser says describe how the firm helped develop a “sophisticated infrastructure of shell companies that were designed to funnel dark money into politics”.

Note: For more along these lines, see concise summaries of deeply revealing news articles on elections corruption from reliable major media sources.

Paul Marik, MD, one of the most highly published critical care physicians in the world and the Director of the ICU at Sentara Norfolk General Hospital, was recently told by Sentara Healthcare that he could no longer administer a range of highly effective COVID-19 treatments to critically ill patients - the same treatments he has successfully used to reduce COVID deaths in the ICU by as much as 50%. The result of the prohibition has been a sharp increase in patient mortality. Because Dr. Marik can no longer stand by while patients needlessly die without proper treatment, he has filed a lawsuit to allow him and his colleagues to administer the combination of FDA-approved drugs and other therapies that has saved thousands of critically ill COVID-19 patients in the last 18 months. The Complaint filed today in the Circuit Court for the City of Norfolk, Virginia states that Sentara Healthcare is "preventing terminally ill COVID patients from exercising their right to choose and to receive safe, potentially life-saving treatment determined to be appropriate for them by their attending physician." Under Virginia law, every patient has the right to receive treatment deemed appropriate for them by their attending physician, and terminally ill patients have the right to try investigational medicines that their treating physician recommends. Through its arbitrary prohibition of the COVID-19 treatment protocol ... Sentara is violating the law and unjustly depriving critically ill patients of lifesaving treatment.

Note: Watch a video detailing successes with these treatments and obstruction by authorities of these life-saving treatments. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

Lowering prescription drug prices is among the Biden administration's most urgent priorities. But the drug industry is spending big to keep that from happening. A new compromise on Capitol Hill would offer some relief from high prices by gradually allowing Medicare to negotiate drug prices similar to private insurers for the first time, while capping out of pocket costs at $2,000 and setting limits on the cost of insulin. The pharmaceutical industry has spent nearly $263 million on lobbying so far this year, employing three lobbyists for every member of Congress, according to OpenSecrets, which tracks money in politics. Millions of those dollars are in the form of campaign donations. "They have really endless resources to throw at shaping the outcomes of legislation," said Sheila Krumholz, the executive director of OpenSecrets. Congressman Scott Peters, a Democrat, sparked protests outside his San Diego district office when he came out against a plan to cut drug costs for seniors earlier this year. He's received nearly $130,000 from the industry this year. About $100,000 has been donated to Democratic Senator Kyrsten Sinema this year. Senator Robert Menendez, also a Democrat, has taken nearly $80,000 in 2021. "Bottom line is I'm supporting a price negotiation bill that has been worked out," ... Menendez said when asked what message he's sending by taking money from the pharmaceutical industry.

Note: This article fails to mention that big Pharma spends more than any other sector on lobbying and also is the largest sponsor of advertising in the major media. Do you think the media and Congress are biased by this? For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in the pharmaceutical industry from reliable major media sources.

For years, the Gates Foundation has been steered by an unusually small board of trustees, made up of Bill, his estranged wife, Melinda, and the billionaire investor Warren Buffett. The larger the foundation became, the less anyone seemed willing to ask tough questions about its secretive management structure or its penchant for giving money to lucrative pharmaceutical and credit card companies such as Mastercard, despite the fact that giving away billions to wealthy corporations set an unusual and troubling precedent in the philanthropic sector. Billionaires who make their fortunes through corporate practices that undercut workers and deepen inequality – like corporate tax avoidance, insufficient sick pay and the immoral gap in pay between executives and low-paid workers – are not the solution to problems they generate. Asking Bill Gates to fix inequality is like asking an arsonist to hose down your house after he just set it on fire. In April last year, the University of Oxford was reportedly considering offering a Covid-19 vaccine developed by its scientists on a nonexclusive basis. But then, Kaiser Health News reported, "Oxford – urged on by the Bill & Melinda Gates Foundation – reversed course. It signed an exclusive vaccine deal with AstraZeneca that gave the pharmaceutical giant sole rights and no guarantee of low prices." This dealmaking .. seemed to conflict with the Gates Foundation's stated mission to improve global access to medicines, but it's not surprising.

Note: Read more about the Gates Foundation's startling degree of media influence during the pandemic. For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and the coronavirus vaccine from reliable major media sources.

A video showing a mobile device snapping infrared images of an iPhone user is circulating around the internet. In the Tik Tok shared by user Brie Thomason, a digital camera using an infrared lens is seen filming an iPhone user observing their home screen. As the iPhone user stares blatantly at the device, Thomason's digital camera captures the iPhone snapping multiple infrared images every 5-10 seconds. While this discovery may cause some users to panic, Apple claims this is actually just an aspect of the iPhone that allows users to control their face ID and Animoji (the animated emoji function). According to Apple, this feature was first debuted as the iPhone X's most groundbreaking function; since it is not even discernible at first glance, even though it literally stares you in the face. The company calls this feature: the new TrueDepth IR camera. This camera, housed in the black notch at the top of the display, includes a number of high-tech components such as a "flood illuminator," infrared (IR) camera, and an infrared emitter. Officials say as an iPhone is used, the latter emits 30,000 infrared dots in a known pattern when a face is detected, enabling the iPhone X to generate a 3D map of a user's face. According to the team, this TrueDepth IR camera can also do this fast enough to support the creation of 3D motion data as well. So, yes, your iPhone is essentially taking "invisible" photos of you, but not for the reasons you would think.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and the disappearance of privacy from reliable major media sources.

Research Medical's owner, HCA Healthcare Inc., is a profitable, publicly traded network of 185 hospitals. Even in the year of Covid-19, 2020, the company generated $51.5 billion in revenue and increased its pretax earnings by 3.6 percent. That performance helped boost the total compensation HCA's chief executive, Samuel N. Hazen, received last year to $30.4 million, a 13 percent rise from 2019. The total worth of his compensation package equaled 556 times the compensation received by the median employee at HCA – $54,651. The figures highlight the growing CEO pay gap, a problem among many public companies according to some investors and workers and even a few CEOs. In 2019, for example, the average pay ratio among 350 large American companies was 320-to-1, according to research by the Economic Policy Institute. In 1989, the average was 61-to-1. Because [Jamelle] Brown, [an] emergency department worker, makes even less than the median, Hazen got roughly 1,000 times Brown's pay. Brown says he lives with his sister because he doesn't earn enough from his job at Research Medical to pay for his own apartment. HCA isn't alone in paying its chief executive vastly more than what rank-and-file workers earn. Acuity Brands, an industrial technology company, paid its CEO, Neil M. Ashe, $21 million last year, or 2,316 times the median employee's pay. Starbucks ... paid its CEO, Kevin Johnson, $14.7 million last year. That was 1,211 times the pay of its median employee.

Note: For more along these lines, see concise summaries of deeply revealing news articles on income inequality from reliable major media sources.

With few exceptions, big businesses are having a very different year from most of the country. Between April and September, one of the most tumultuous economic stretches in modern history, 45 of the 50 most valuable publicly traded U.S. companies turned a profit. Despite their success, at least 27 of the 50 largest firms held layoffs this year, collectively cutting more than 100,000 workers. Corporate leaders are touting their success and casting themselves as leaders on the road to economic recovery. Many of their firms have put Americans out of work and used their profits to increase the wealth of shareholders. 21 big firms that were profitable during the pandemic laid off workers anyway. Berkshire Hathaway raked in profits of $56 billion during the first six months of the pandemic while one of its subsidiary companies laid off more than 13,000 workers. Salesforce, Cisco Systems and PayPal cut staff even after their chief executives vowed not to do so. Companies sent thousands of employees packing while sending billions of dollars to shareholders. Walmart, whose CEO spent the past year championing the idea that businesses "should not just serve shareholders," nonetheless distributed more than $10 billion to its investors during the pandemic while laying off 1,200 corporate office employees. Economists estimate at least 100,000 small businesses permanently closed in the first two months of the pandemic alone.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and the coronavirus from reliable major media sources.

Netflix’s brilliant new 90-minute docu-drama, The Social Dilemma ... might be the most important watch of recent years. The film, which debuted at Sundance Film Festival in January, takes a premise that’s unlikely to set the world alight ... ie that Facebook, Twitter, Instagram et al aren’t exactly creating a utopia. Its masterstroke is in recruiting the very Silicon Valley insiders that built these platforms to explain their terrifying pitfalls – which they’ve realised belatedly. You don’t get a much clearer statement of social media’s dangers than an ex-Facebook executive’s claim that: “In the shortest time horizon I’m most worried about civil war.” The commonly held belief that social media companies sell users’ data is quickly cast aside – the data is actually used to create a sophisticated psychological profile of you. What they’re selling is their ability to manipulate you, or as one interviewee puts it: “It’s the gradual, slight, imperceptible change in your own behaviour and perception. It’s the only thing for them to make money from: changing what you do, how you think, who you are.” Despite it being public knowledge that Vote Leave and Trump’s 2016 election campaign harvested voters’ Facebook data on a gigantic scale, The Social Dilemma still manages to find fresh and vital tales of how these platforms destabilise modern politics. Russia’s Facebook hack to influence the 2016 US election? “The Russians didn’t hack Facebook. They used the tools that Facebook made for legitimate advertisers,” laments one of the company’s ex-investors.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and media manipulation from reliable sources.

The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. Gilead Sciences announced the price Monday for remdesivir, and said the price would be $3,120 for patients with private insurance. The amount that patients pay out of pocket depends on insurance, income and other factors. The price was swiftly criticized; a consumer group called it “an outrage” because of the amount taxpayers invested toward the drug's development. In 127 poor or middle-income countries, Gilead is allowing generic makers to supply the drug; two countries are doing that for around $600 per treatment course. The drug, given through an IV, interferes with the coronavirus’s ability to copy its genetic material. In a U.S. government-led study, remdesivir shortened recovery time by 31% — 11 days on average versus 15 days for those given just usual care. Peter Maybarduk, a lawyer at the consumer group Public Citizen, called the price “an outrage.” “Remdesivir should be in the public domain” because the drug received at least $70 million in public funding toward its development, he said. “The price puts to rest any notion that drug companies will ‘do the right thing’ because it is a pandemic,” Dr. Peter Bach, a health policy expert ... said. “The price might have been fine if the company had demonstrated that the treatment saved lives. It didn’t.”

Note: The March coronavirus package passed in the U.S. "not only omitted language that would have limited drug makers’ intellectual property rights, it specifically prohibited the federal government from taking any action if it has concerns that the treatments or vaccines developed with public funds are priced too high." While many suffer economically from the virus, big Pharma is raking in big bucks. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption and the coronavirus from reliable major media sources.

The global insulin market is dominated by three companies: Eli Lilly, the French company Sanofi and the Danish firm Novo Nordisk. All three have raised list prices to similar levels. According to IBM Watson Health data, Sanofi’s popular insulin brand Lantus was $35 a vial when it was introduced in 2001; it’s now $270. Novo Nordisk’s Novolog was priced at $40 in 2001, and as of July 2018, it’s $289. The companies appear to have increased [prices] in lockstep over a number of years, prompting allegations of price fixing. All three companies denied these charges. (In 2010, Mexico fined Eli Lilly and three Mexican companies for price collusion on insulin, an allegation Eli Lilly also denied.) In the United States, a federal prosecutor and at least five state attorneys general are currently investigating the companies’ pricing practices. There is also another, less known corporate entity in the mix: pharmacy benefit managers (PBMs), which include Express Scripts, OptumRx and CVS Health; all are now named in lawsuits on high insulin prices. These corporate entities are powerful special interests. In 2017, the pharmaceutical and health product industry ... spent nearly $280 million on lobbying, the biggest spender by far of 20 top industries, according to the Center for Responsive Politics. The industry also has a revolving door to government. Alex Azar, the head of the Department of Health and Human Services, was the president of Eli Lilly’s U.S. division until 2017.

Note: For more along these lines, see concise summaries of deeply revealing news articles on pharmaceutical industry corruption from reliable major media sources.

[Don] Poldermans was a prolific medical researcher at Erasmus Medical Center in the Netherlands, where he analyzed the standards of care for cardiac events after surgery, publishing a series of definitive studies from 1999 until the early 2010s. One crucial question he studied: Should you give patients a beta blocker, which lowers blood pressure, before certain surgeries? Poldermans's research said yes. European medical guidelines (and to a lesser extent US guidelines) recommended it accordingly. The problem? Poldermans's data was reportedly fake. A 2012 inquiry by Erasmus Medical School, his employer, into allegations of misconduct found that he "used patient data without written permission, used fictitious data and ... submitted to conferences [reports] which included knowingly unreliable data." Poldermans admitted the allegations and apologized. After the revelations, a new meta-analysis was published in 2014, evaluating whether to use beta blockers before non-cardiac surgery. It found that a course of beta blockers made it 27 percent more likely that someone would die within 30 days of their surgery. Millions of surgeries were conducted across the US and Europe during the years from 2009 to 2013 when those misguided guidelines were in place. One provocative analysis ... estimated that there were 800,000 deaths compared to if the best practices had been established five years sooner.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in science and in Big Pharma from reliable major media sources.

Once upon a time ... Google was truly great. A couple of lads at Stanford University in California had the idea to build a search engine that would crawl the world wide web, create an index of all the sites on it and rank them by the number of inbound links each had from other sites. The arrival of ChatGPT and its ilk ... disrupts search behaviour. Google's mission – "to organise the world's information and make it universally accessible" – looks like a much more formidable task in a world in which AI can generate infinite amounts of humanlike content. Vincent Schmalbach, a respected search engine optimisation (SEO) expert, thinks that Google has decided that it can no longer aspire to index all the world's information. That mission has been abandoned. "Google is no longer trying to index the entire web," writes Schmalbach. "In fact, it's become extremely selective, refusing to index most content. This isn't about content creators failing to meet some arbitrary standard of quality. Rather, it's a fundamental change in how Google approaches its role as a search engine." The default setting from now on will be not to index content unless it is genuinely unique, authoritative and has "brand recognition". "They might index content they perceive as truly unique," says Schmalbach. "But if you write about a topic that Google considers even remotely addressed elsewhere, they likely won't index it. This can happen even if you're a well-respected writer with a substantial readership."

Note: WantToKnow.info and other independent media websites are disappearing from Google search results because of this. For more along these lines, see concise summaries of deeply revealing news articles on AI and censorship from reliable sources.

A growing number of supermarkets in Alabama, Oklahoma, and Texas are selling bullets by way of AI-powered vending machines, as first reported by Alabama's Tuscaloosa Thread. The company behind the machines, a Texas-based venture dubbed American Rounds, claims on its website that its dystopian bullet kiosks are outfitted with "built-in AI technology" and "facial recognition software," which allegedly allow the devices to "meticulously verify the identity and age of each buyer." As showcased in a promotional video, using one is an astoundingly simple process: walk up to the kiosk, provide identification, and let a camera scan your face. If its embedded facial recognition tech says you are in fact who you say you are, the automated machine coughs up some bullets. According to American Rounds, the main objective is convenience. Its machines are accessible "24/7," its website reads, "ensuring that you can buy ammunition on your own schedule, free from the constraints of store hours and long lines." Though officials in Tuscaloosa, where two machines have been installed, [said] that the devices are in full compliance with the Bureau of Alcohol, Tobacco, Firearms and Explosives' standards ... at least one of the devices has been taken down amid a Tuscaloosa city council investigation into its legal standing. "We have over 200 store requests for AARM [Automated Ammo Retail Machine] units covering approximately nine states currently," [American Rounds CEO Grant Magers] told Newsweek, "and that number is growing daily."

Note: Facial recognition technology is far from reliable. For more along these lines, see concise summaries of deeply revealing news articles on artificial intelligence from reliable major media sources.

The Grab [is] a riveting new documentary which outlines the move by national governments, financial investors and private security forces to snap up food and water resources. What oil was to the 20th century, food and water will be to the 21st – precious, geopolitically powerful and contested. "The 20th century had Opec," says [Nate] Halverson ... a journalist with the Center for Investigative Reporting. "In the future, we're going to have Food Pec. [In] rural La Paz county, Arizona, a Saudi company bought about 15 square miles of farmland [and] drained the region's aquifers beyond a generation's worth of rain. Residents describe going without water, discovering empty wells, their houses cracked and sinking, with little recourse. The film connects their confusion to the despair of Zambian farmers displaced, via a complicated and westernized deeds system, by mercenary militias to make way for commercial farmland controlled by outside actors from various countries – China, Gulf states, the US. The culprit is not one country or company but a shadowy network of mercenary interests. Halverson and his team [obtained] ... a year's worth of emails within the private equity firm Frontier Resource Group, founded by Erik Prince, who also founded and was the CEO of the military contracting company Blackwater – a notorious mercenary group during the US invasion of Iraq. The emails, from 2012, reveal a clear plan to obtain, by whatever means necessary, land in Africa to fulfill competing national interests. "I just want people to have great information ... because right now the people that have this information are the CIA, and Wall Street, and foreign governments and very wealthy people."

Note: Why is the founder of Blackwater, a US defense contractor tied to countless scandals and criminal activities, buying up land in Africa? For more along these lines, see concise summaries of deeply revealing news articles on food system corruption from reliable major media sources.

New data from the National Institutes of Health reveal the agency and its scientists collected $710 million in royalties during the pandemic, from late 2021 through 2023. These are payments made by private companies, like pharmaceuticals, to license medical innovations from government scientists. Almost all that cash – $690 million – went to the National Institute of Allergy and Infectious Diseases, the subagency led by Dr. Anthony Fauci, and 260 of its scientists. Information about this vast private royalty complex is tightly held by the National Institutes of Health (NIH). My organization, OpenTheBooks.com, was forced to sue to uncover the royalties paid from September 2009 to October 2021, which amounted to $325 million over 56,000 transactions. Payments skyrocketed during the pandemic era: Those years saw more than double the amount of cash flow to NIH from the private sector, compared to the prior 12 combined. All told, it's $1.036 billion. NIH is still redacting pieces of the data that would help us more easily connect therapeutics with their government-paid inventors. For example, they refuse to show us the amount of royalties paid to each individual scientist. So we still can't entirely follow the money. In the meantime, Sen. Rand Paul (R-Ky.) has sponsored the Royalty Transparency Act, which sailed unanimously through the committee process and deserves a floor vote immediately.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in the pharmaceutical industry from reliable major media sources.

Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.